Germline Genetic Testing After Cancer Diagnosis
Allison W. Kurian(Stanford University), Steven J. Katz(University of Michigan), Rachel Hodan(Cancer Institute (WIA)), Paul Abrahamse(University of Michigan), Allison Furgal(University of Michigan), Jonathan S. Berek(Stanford Health Care), Lily Hoang(Ambry Genetics (United States)), Timothy P. Hofer(University of Michigan), Amal Yussuf(Ambry Genetics (United States)), Lisa R. Susswein, Kevin C. Ward(Emory University), Scarlett Lin Gomez(University of California, San Francisco), Ann S. Hamilton(University of Southern California), Lihua Liu(Hebei Medical University), Rachel Tocco(University of Michigan), Thomas P. Slavin(Myriad Genetics), Edward D. Esplin(Stanford University)
Cited by 160
Related Papers
Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer
|New England Journal of Medicine|2016|2.5k
Concurrent Chemotherapy and Pelvic Radiation Therapy Compared With Pelvic Radiation Therapy Alone as Adjuvant Therapy After Radical Surgery in High-Risk Early-Stage Cancer of the Cervix
|Journal of Clinical Oncology|2000|2.3k
Rethinking ovarian cancer: recommendations for improving outcomes
|Nature reviews. Cancer|2011|1.5k
Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer
|Nature reviews. Cancer|2015|1.4k